2023
DOI: 10.1097/hs9.0000000000000844
|View full text |Cite
|
Sign up to set email alerts
|

Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…Three out of the seven papers aim to determine the impact of genetic data and clinical features also supporting disease management. This is also reflected by the role of genomics in personalized medicine for hemoglobinopathies in several ongoing international initiatives, such as the NHLBI TOPMed Program [ 11 ], the International Hemoglobinopathy Research Network (INHERENT) [ 12 ], and GenoMed4All [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…Three out of the seven papers aim to determine the impact of genetic data and clinical features also supporting disease management. This is also reflected by the role of genomics in personalized medicine for hemoglobinopathies in several ongoing international initiatives, such as the NHLBI TOPMed Program [ 11 ], the International Hemoglobinopathy Research Network (INHERENT) [ 12 ], and GenoMed4All [ 13 ].…”
Section: Discussionmentioning
confidence: 99%